Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen holds 0.6 ml of solution — and that single volume delivers four separate weekly doses regardless of which strength you are using. So if you have read about 0.6 ml Mounjaro or noticed the figure on the device itself, you are looking at the total fill volume of the pen, not a dose measurement. Understanding the distinction matters, because the dose your prescriber sets is expressed in milligrams, not millilitres. Mounjaro is a prescription-only medicine, so a GPhC-registered prescriber must assess whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common confusion around this number is assuming that 0.6 ml describes a single injection. It does not. The 0.6 ml is the full liquid volume loaded into the pen at manufacture, enough for a four-week supply of once-weekly injections. Each time you use the pen, the device dispenses one quarter of that volume automatically. You press the button; the mechanism does the measuring.
Why does this matter? Because people sometimes ask whether they should be taking "0.6 ml" or try to compare their treatment to someone else's by volume rather than by milligrams. The milligram strength printed on the pen label (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg) is the clinically meaningful number. That figure tells your prescriber how much active tirzepatide reaches your system each week. The 0.6 ml tells you nothing about the dose; it tells you how much solution Eli Lilly put in the device. You can read more about how the different Mounjaro strengths relate to each other on our tirzepatide overview page.
The NHS's patient information for tirzepatide explains this clearly: the pen is pre-set, and patients are not required to handle syringes, measure volumes or perform any dose calculation. If you have questions about what your pen's label says, the right person to ask is your prescriber, not a search engine.
The pen is a pre-filled, disposable auto-injector containing a clear, colourless-to-slightly-yellow solution. All six strengths share the same 0.6 ml fill. The concentration of tirzepatide differs between strengths (more milligrams dissolved in the same volume of liquid) which is why the label changes but the pen size does not.
When a pen is dispensed through a regulated UK pharmacy such as ours, it arrives in plain, unbranded packaging via DPD with a tracking link sent to your phone; inside you will find the KwikPen itself, a package leaflet, and a notice confirming the prescription. The pen goes straight into the fridge door when you get home. Four needles are used across the four weeks, one per injection, a fresh needle each time. Our Mounjaro information page covers storage and injection-site rotation in more detail.
The pen's 0.6 ml volume is standardised by Eli Lilly specifically so that the device can be identical across the dose range, simplifying manufacturing and making the experience consistent for patients whatever strength they are on. It is a design feature, not a clinical variable.
Tirzepatide treatment starts at 2.5 mg for the first four weeks. That is a tolerability period: the lower dose allows your body to adjust before the prescriber considers moving to 5 mg, then potentially 7.5 mg and higher in subsequent steps. At every stage, the pen your pharmacy dispenses holds the same 0.6 ml; only the concentration (and therefore the milligram strength) changes.
This is worth understanding because some people notice that a pen at a higher strength looks identical to their previous one and wonder whether a dispensing error has occurred. The outer label and the sticker on the cartridge inside will both show the correct milligram strength. If you ever have a genuine concern about what you have received, contact your prescribing service immediately and, if necessary, your dispensing pharmacy. A guide to understanding how different prescribed strengths compare is available on our page covering Mounjaro volumes and strengths.
Dose decisions are clinical. Under NICE's guidance on tirzepatide (TA1026), treatment is reviewed if adequate weight loss is not achieved at the highest tolerated dose. Your prescriber (not the volume of solution in the pen) determines the right milligram strength for your circumstances at each review.
Search results and pharmacy information pages sometimes reference Mounjaro volumes that differ from 0.6 ml. This usually reflects one of two things: a page covering a different product (such as semaglutide, whose Wegovy pens have a different fill), or a page discussing individual injection volumes rather than the pen's total capacity. If you have come across references to a 0.6 ml Mounjaro pen and want to understand exactly what that measurement means, our dedicated page explains the figure in full. Our 5 ml Mounjaro page addresses a similarly common number that searches turn up, and explains what that figure refers to in context.
Tirzepatide's clinical profile (the SURMOUNT-1 trial, published in the New England Journal of Medicine, found average body-weight reductions of around 20–21% at the 15 mg maintenance dose over 72 weeks) is tied entirely to the milligram dose, not to any volume figure. If you are comparing information across sources and see a volume number that doesn't match 0.6 ml, check which product and which measurement is being described before drawing conclusions.
Some patients also encounter references to 1 ml or other volumes in the context of compounded or unlicensed preparations. Those are not licensed Mounjaro. The only legal supply of tirzepatide for weight management in the UK comes through the licensed supply chain, dispensed on a valid prescription from a pharmacy registered with the GPhC. Our about us page sets out how our pharmacy fits into that framework. For a broader look at what treatment might involve for you, including detail on the 10 ml Mounjaro references you may have encountered and what they actually describe, our weight-loss treatment overview is a practical starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.